#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Internal Medicine / 2018 - 7-8

Endothelial function, its relation to arterial hypertension and the possibility of its modulation

Czech version

Authors: Vladislav Biel 1;  Jan Novák 2;  Luděk Pluháček 1;  Jiří Špác 2
Authors‘ workplace: Interní oddělení Nemocnice Boskovice 1;  II. interní klinika LF MU a FN u sv. Anny, Brno 2
Published in: Vnitř Lék 2018; 64(7-8): 762-770
Category: Reviews

Overview

Endothelium has both a protective and a very complex para-, endo- and autocrine functions. Vascular tone is determined as a balance between the production of vasodilating and vasoconstrictive substances. Among the most important vasodilators are nitric oxide (NO), PGI2, endothelial-derived hyperpolarizing factor (EDHF), adenosine and others, among the most important vasoconstrictors, endothelin-1 and angiotensin-2. Therapeutic goal of improving endothelial secretory function should be maximizing production of vasodilators and minimizing production of vasoconstrictors. Improvement of endothelial function can be achieved most effectively by following a healthy lifestyle (changing the diet to a Mediterranean type, sufficient physical activity, weight reduction and smoking cessation) and by initiating the treatment with ACE inhibitors and statins, when indicated. Large number of trials have shown that all of these interventions improve the prognosis of patients and a part of this effect may be mediated by improving endothelial dysfunction.

Key words:

endothelial dysfunction – endothelium – hypertension

Sources
  1. Jasparse JL, Laughlin MH. Endothelial Function and Exercise Training: Evidence from Studies Using Animal Models. Med Sci Sports Exerc 2006; 38(3): 445–454. Dostupné z DOI: <http://dx.doi.org/10.1249/01.mss.0000191187.24525.f2>.
  2. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2(8670): 997–1000.
  3. Wang Y, Cheng KK, Lam KS et al. APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 in mice. Diabetes 2011; 60(11): 3044–3054. Dostupné z DOI: <http://dx.doi.org/10.2337/db11–0666>. Erratum in Erratum. APPL1 Counteracts Obesity-Induced Vascular Insulin Resistance and Endothelial Dysfunction by Modulating the Endothelial Production of Nitric Oxide and Endothelin-1 in Mice. Diabetes 2011; 60: 3044–3054.
  4. Moncada S, Gryglewski R, Bunting S et al. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263(5579): 663–665.
  5. Garczorz W, Francuz T, Gmiński J et al. Influence of elastin-derived peptides, glucose, LDL and oxLDL on nitric oxide synthase expression in human umbilical artery endothelial cells. Acta Biochim Pol 2011; 58(3): 375–379.
  6. Parkington HC, Coleman HA, Tare M. Prostacyclin and endothelium-dependent hyperpolarization. Pharmacol Res 2004; 49(6): 509–514. Dostupné z DOI: <http://dx.doi.org/10.1016/j.phrs.2003.11.012>.
  7. Shimokawa H, Morikawa K. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. J Mol Cell Cardiol 2005; 39(5): 725–732. Dostupné z DOI: <http://dx.doi.org/10.1016/j.yjmcc.2005.07.007>.
  8. Soltis EE, Cassis LA. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens 1991; 275: 681–692.
  9. Atzmon G, Pollin TI, Crandall J et al. Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci 2008; 63(5): 447–453.
  10. Yamagishi SI, Edelstein D, Du XL et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276(27): 25096–25100. Dostupné z DOI: <http://dx.doi.org/10.1074/jbc.M007383200>.
  11. Shankar A, Xiao J. Positive relationship between plasma leptin level and hypertension. Hypertension 2010; 56(4): 623–628. Dostupné z DOI: <http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.148213>.
  12. Shek EW, Brands MW, Hall JE. Chronic Leptin Infusion Increases Arterial Pressure. Hypertension 1998; 31(1 Pt 2): 409–414.
  13. Korda M, Kubant R, Patton S et al. Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol 2008; 295(4): H1514-H1521. Dostupné z DOI: <http://dx.doi.org/10.1152/ajpheart.00479.2008>.
  14. Hosoki R, MatsukiN, Kimura H. The possible role of hydrogen sulfi de as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237(3): 527–531. Dostupné z DOI: <http://dx.doi.org/10.1006/bbrc.1997.6878>.
  15. Skovgaard N, Gouliaev A, Aalling M et al. The role of endogenous H2S in cardiovascular physiology. Curr Pharm Biotechnol 2011; 12(9): 1385–1393.
  16. Balazy M, Abu-Yousef IA et al. Identification of carbonyl sulfi de and sulfur dioxide in porcine coronary artery by gas chromatography/mass spectrometry, possible relevance to EDHF. Biochem Biophys Res Commun 2003; 311(3): 728–734.
  17. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000; 279(6): L1029-L1037. Dostupné z DOI: <http://dx.doi.org/10.1152/ajplung.2000.279.6.L1029>.
  18. Milne GR, Palmer MT. Anti-Inflammatory and Immunosuppressive Effects of the A2A Adenosine Receptor. ScientificWorldJournal 2011; 11: 320–339. Dostupné z DOI: <http://dx.doi.org/10.1100/tsw.2011.22>.
  19. O’Brien RF, Robbins RJ, McMurtry IF. Endothelial cells in culture produce a vasoconstrictor substance. J Cell Physiol 1987; 132(2): 263–270. Dostupné z DOI: <http://dx.doi.org/10.1002/jcp.1041320210>.
  20. Masaki T. The discovery of endotelins. Cardiovasc Res 1998; 39(3): 530–533.
  21. Kawanabe Y, Nauli SM. Endothelin. Cell Mol Life Sci 2011; 68(2): 195–203. Dostupné z DOI: <http://dx.doi.org/10.1007/s00018–010–0518–0>.
  22. Ak G, Buyukberber S, Sevinc S et al. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus. J Diabetes Compl 2001; 15(3): 150–157.
  23. Sen P, Gopalakrishnan R, Kothari H et al. Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection. Blood 2011; 117(11): 3199–3208. Dostupné z DOI: <http://dx.doi.org/10.1182/blood-2010–09–310706>.
  24. Oh SJ, Ha WC, Lee JI et al. Angiotensin II Inhibits Insulin Binding to Endothelial Cells. Diabetes Metab J 2011; 35(3): 243–247. Dostupné z DOI: <http://dx.doi.org/10.4093/dmj.2011.35.3.243>.
  25. Liu H, Yang Y, Huang G et al. Positive association of pro-inflammatory biomarkers and increased oxidative stress in the healthy elderly. Arch Gerontol Geriatr 2012; 54(2): e8-e12. Dostupné z DOI: <http://dx.doi.org/10.1016/j.archger.2011.05.016>.
  26. Karásek D, Vaverková H, Halenka M. Endoteliální dysfunkce, možnosti její detekce a využití v klinické praxi. Interní Med 2005; 6(9): 450–453.
  27. Su Y, Han W, Giraldo C et al. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1998; 19(5): 819–825. Dostupné z DOI: <http://dx.doi.org/10.1165/ajrcmb.19.5.3091>.
  28. Nadler JL, Velasco JS, Horton R. Cigarette smoking inhibits prostacyclin formation. Lancet 1983; 1(8336): 1248–1250.
  29. Haak T, Jungmann E, Raab C et al. Elevated endothelin-1 levels after cigarette smoking. Metab Clin Exp 1994; 43(3): 267–269.
  30. Perticone F, Ceravolo R, Candigliota M et al. Obesity and Body Fat Distribution Induce Endothelial Dysfunction by Oxidative Stress: Protective Effect of Vitamin C. Diabetes 2001; 50(1): 159–165.
  31. Woo KS, Chook P, Yu C. et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004; 109(16): 1981–1986.
  32. Brook RD, Bard RL, Glazewski L et al. Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults. Am J Cardiol 2004; 93(8): 1012–1016. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjcard.2004.01.009>.
  33. Walther C, Gielen S, Hambrecht R. The effect of exercise training on endothelial function in cardiovascular disease in humans. Exerc Sport Sci Rev 2000; 32(4): 129–134.
  34. Hambrecht R, Wolf A, Gielen S et al. Effect of Exercise on Coronary Endothelial Function in Patients with Coronary Artery Disease. N Engl J Med 2000; 342(7): 454–460.
  35. Di Francescomarino S, Sciartilli A, Di Valerio P et al. The effect of physical exercise on endothelial function. Sports Med 2009; 39(10): 797–812. Dostupné z DOI: <http://dx.doi.org/10.2165/11317750–000000000–00000>.
  36. Kris-Etherton P, Eckel RH, Howard BV et al. AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation 2001; 103(13): 1823–1825.
  37. Vogel RA, Corretti MC, Plotnick GD. Effect of a Single High-Fat Meal on Endothelial Function in Healthy Subjects. Am J Cardiol 1997; 79(3): 350–354.
  38. Duffy SJ, Keaney JF, Holbrook M et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001; 104(2): 151–156.
  39. Stein JH, Keevil JG, Wiebe DA et al. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 1999; 100(10): 1050–1055.
  40. Agewall S, Wright S, Doughty RN et al. Does a glass of red wine improve endothelial function? Eur Heart J 2000; 21(1): 74–78. Dostupné z DOI: <http://dx.doi.org/10.1053/euhj.1999.1759>.
  41. Gazis A, White DJ, Page SR et al. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med 1999; 16(4): 304–311.
  42. Title LM, Cummings PM, Giddens K et al. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 2000; 36(3): 758–765.
  43. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355(9200): 253–259. Erratum in Lancet 2000; 356(9232): 860.
  44. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravivenza nell’Infarto miocardico. Lancet 1999; 354: 447–455.
  45. Perticone F, Ceravolo R, Maio R et al. Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients. Atherosclerosis 2000; 152(2): 511–518.
  46. Mancini GB, Henry GC, Macaya C et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94(3): 258–265. Erratum in Circulation 1996; 94(6): 1490.
  47. Ridker PM, Everett BM, Thuren T et al. CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 2017; 377(12): 1119–1131. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1707914>.
  48. Brown NJ, Abbas A, Byrne D et al. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women. Circulation 2002; 105(3): 304–309.
  49. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288(3): 321–333.
  50. Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280(7): 605–613.
  51. Moreau KL, Meditz A, Deane KD et al. Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women. Am J Physiol Heart Circ Physiol 2012; 302(5): H1211-H1218. Dostupné z DOI: <http://dx.doi.org/10.1152/ajpheart.01065.2011>.
  52. Widlansky ME, Gokce N, Keaney JF et al. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42(7): 1149–1160.
  53. Al-Qaisi M, Kharbanda RK, Mittal TK et al. Measurement of endothelial function and its clinical utility for cardiovascular risk. Vasc Health Risk Manag 2008; 4(3): 647–652.
  54. Souhrn evropských doporučení pro prevenci kardiovaskulárních onemocnění. Dostupné z WWW: <www.kardio-cz.cz/data/upload/Souhrn_Evropskych_doporuceni_pro_prevenci.pdf>.
Labels
Diabetology Endocrinology Internal medicine
The Scottish model of vancomycin dosing and therapeutic drug monitoring improves both efficacy and safety of vancomycin therapy
Mesenchymal stem cells and type 1 diabetes treatment
How to diagnose cardiac sarcoidosis?
Future of pharmacological treatment of non-alcoholic steatohepatitis in terms of key pathophysiological mechanisms
Low-carbohydrate diet in diabetes mellitus treatment
Controversies in the treatment of gout
Myocardial injury after carbon monoxide intoxication in suicide attempt, with features of both toxic and tako-tsubo cardiomyopathy: case report
Spironolactone in the treatment of hypertension: a neglected molecule
Trimeresurus albolabris (white-lipped green pit viper) – bite report: case report
Article was published in

Internal Medicine

Issue 7-8
2018 Issue 7-8
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#